HSINCHU, June 19, 2024 /PRNewswire/ — M31 Technology Corporation (M31), a global provider of silicon intellectual property (IP), announced the launch of the latest LPDDR memory IP solution to meet the growing demand in the high-performance computing (HPC) application market, even looking beyond the computing power to the artificial intelligence (AI) field, where there is […]
Category Archives: Pr Newswire
HONG KONG and SHANGHAI, June 19, 2024 /PRNewswire/ — The “Ping An Family Doctor Brand Upgrade Conference” was held in Shanghai recently. Ping An Insurance (Group) Company of China, Ltd. (hereafter “Ping An” or the “Group”, HKEX: 2318 / 82318; SSE: 601318) has upgraded its “Ping An Family Doctor” brand with a one-stop, proactive health management […]
19
Jun
Jun
VANCOUVER, British Columbia, June 18, 2024 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company”) announces the results of its annual general and special meeting of common shareholders held on June 18, 2024 in Vancouver. Resolutions passed at the meeting included the appointment of Saturna Group Chartered Accountants LLP as auditors […]
Pr Newswire
Tempest to Report New Data from Global Randomized Combination Study of Amezalpat (TPST-1120) in First-Line Hepatocellular Carcinoma
19
Jun
Jun
Webcasted conference call on Thursday, June 20, 2024 at 8:30 a.m. ET BRISBANE, Calif., June 18, 2024 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced the company plans to report new data from the global randomized Phase 1b/2 combination study […]
19
Jun
Jun
SAN DIEGO and TORONTO, June 18, 2024 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, today announced the voting results from the Company’s annual and special meeting of shareholders held today, June 18, 2024 […]
19
Jun
Jun
MIAMI, June 18, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage regenerative medicine biotechnology company developing cellular therapies for rare, life-threatening and chronic aging-related conditions, today announced the closing of its previously announced exercise of certain existing warrants to purchase an aggregate of 1,697,891 shares of its Class A […]
19
Jun
Jun
SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that Faraz Ali, Chief Executive Officer, will participate in the TD Cowen Genetic Medicines & […]
Clinical investigators complete record enrollment in real-world Registry, HEAL (An All-comers Registry of the MicroStent PeripHeral Vascular StEnt in subjects with PeripherAl ArteriaL Disease) WILMINGTON, Mass., June 19, 2024 /PRNewswire/ — Micro Medical Solutions — Micro Medical Solutions, a leader in providing innovative medical device solutions, is excited to announce that it has achieved a […]
LONDON, June 19, 2024 /PRNewswire/ — Naran Automotive, the first hypercar company to be founded by a hypercar connoisseur, will introduce the Naran hyper-coupé on 21 June in Andermatt, Switzerland. Thirty-nine Naran hyper-coupés will be built, priced from €2 million each, to a rare level of bespoke design and craftsmanship, and each will be christened […]
TAIPEI, June 19, 2024 /PRNewswire/ — On the afternoon of June 16, 2024, the Chinese Debate Promotion Association (CDPA) hosted the “Debate: Professional Dialogue and Civic Criticism on Smoking Control and Prevention” at the Sun Yun-Suan Memorial Museum. Veteran debaters Yi-Fu Zhao (趙翊夫), Yu-Chen Hung (洪玉珍), Nai-Kang Chang (張乃剛), and Jing-Ying Xiao (蕭靖穎) engaged in […]